The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies

• Autores principales: Hae Jung eChon (Autor), Kyoung Jun eBae (Autor), Yura eLee (Autor), Jiyeon eKim (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2015-03-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

The casein kinase 2 (CK2) protein kinase is a pro-survival kinase and therapeutic target in treatment of various human cancers. CK2 overexpression has been demonstrated in hematological malignancies, including chronic lymphocytic leukemia, chronic myeloid leukemia, acute lymphoblastic leukemia, acut...